GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.012 |
Evidence |
|
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.012 |
Evidence |
|
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
1.012 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
1.012 |
Evidence |
|
HCK |
IPI00029769 |
STAT3 |
|
1.012 |
Evidence |
|
MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.012 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.012 |
Evidence |
|
KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
RYR1 |
|
1.012 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.012 |
Evidence |
|
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
1.012 |
Evidence |
|
TFAP4 |
TFAP4: Transcription factor AP-4 |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
1.012 |
Evidence |
|
MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.012 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
1.012 |
Evidence |
|
MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
1.012 |
Evidence |
|
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.012 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
DRD1 |
DRD1: D(1A) dopamine receptor |
1.012 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
1.012 |
Evidence |
|
ZNF174 |
ZNF174, ZSCAN8: Zinc finger protein 174 |
ZNF224 |
ZNF224, BMZF2, KOX22, ZNF233, ZNF255, ZNF27: Zinc finger protein 224 |
1.012 |
Evidence |
|
SEC24B |
SEC24B: Protein transport protein Sec24B |
GSN |
GSN: Gelsolin precursor |
1.012 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.012 |
Evidence |
|
KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
1.012 |
Evidence |
|
KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
1.012 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.012 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|